ETF constituents for IHE

Below, a list of constituents for IHE (iShares U.S. Pharmaceuticals ETF) is shown. In total, IHE consists of 50 securities.

Note: The data shown here is as of date Jan 31, 2022 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Join the Alphalerts Newsletter

Lot's of cool shit - financial research, unusual stock/option/crypto picks,
tutorials on how to build a fintech SaaS, free data and feature updates.

Ticker Name Sector Asset Class Market Value Weight (%)
JNJ JOHNSON & JOHNSON Health Care Equity 83098932.78 22.4
PFE PFIZER INC Health Care Equity 74634306.12 20.12
BMY BRISTOL MYERS SQUIBB Health Care Equity 20119935.0 5.42
VTRS VIATRIS INC Health Care Equity 19355623.56 5.22
MRK MERCK & CO INC Health Care Equity 17342185.16 4.68
LLY ELI LILLY Health Care Equity 17183811.36 4.63
RPRX ROYALTY PHARMA PLC CLASS A Health Care Equity 16706822.48 4.5
ELAN ELANCO ANIMAL HEALTH INC Health Care Equity 16306669.42 4.4
ZTS ZOETIS INC CLASS A Health Care Equity 14362686.15 3.87
CTLT CATALENT INC Health Care Equity 13425736.32 3.62
OGN ORGANON Health Care Equity 11653795.41 3.14
JAZZ JAZZ PHARMACEUTICALS PLC Health Care Equity 10555577.76 2.85
PRGO PERRIGO PLC Health Care Equity 5964287.4 1.61
ITCI INTRA CELLULAR THERAPIES INC Health Care Equity 5719722.47 1.54
ARVN ARVINAS INC Health Care Equity 3653390.07 0.98
PBH PRESTIGE CONSUMER HEALTHCARE INC Health Care Equity 3650242.76 0.98
PCRX PACIRA BIOSCIENCES INC Health Care Equity 3636736.0 0.98
CORT CORCEPT THERAPEUTICS INC Health Care Equity 2743446.2 0.74
FOLD AMICUS THERAPEUTICS INC Health Care Equity 2712811.36 0.73
IRWD IRONWOOD PHARMA INC CLASS A Health Care Equity 2290141.08 0.62
SAVA CASSAVA SCIENCES INC Health Care Equity 2016185.93 0.54
CCXI CHEMOCENTRYX INC Health Care Equity 1837079.46 0.5
ZGNX ZOGENIX INC Health Care Equity 1682035.68 0.45
INVA INNOVIVA INC Health Care Equity 1537437.68 0.41
USD USD CASH Cash and/or Derivatives Cash 1473851.36 0.4
MDGL MADRIGAL PHARMACEUTICALS INC Health Care Equity 1458337.61 0.39
AMPH AMPHASTAR PHARMACEUTICALS INC Health Care Equity 1295595.6 0.35
RVNC REVANCE THERAPEUTICS INC Health Care Equity 1089481.8 0.29
HRMY HARMONY BIOSCIENCES HLDG INC Health Care Equity 1087645.86 0.29
AXSM AXSOME THERAPEUTICS INC Health Care Equity 1068025.72 0.29
CPRX CATALYST PHARMACEUTICALS INC Health Care Equity 947081.88 0.26
COLL COLLEGIUM PHARMACEUTICAL INC Health Care Equity 943911.2 0.25
ENDP ENDO INTERNATIONAL PLC Health Care Equity 918833.13 0.25
VNDA VANDA PHARMACEUTICALS INC Health Care Equity 904912.05 0.24
RETA REATA PHARMACEUTICALS INC CLASS A Health Care Equity 893688.46 0.24
ATRS ANTARES PHARMA INC Health Care Equity 744183.09 0.2
NUVB NUVATION BIO INC CLASS A Health Care Equity 739240.18 0.2
NGM NGM BIOPHARMACEUTICALS INC Health Care Equity 700568.96 0.19
TBPH THERAVANCE BIOPHARMA INC Health Care Equity 662966.52 0.18
OMER OMEROS CORP Health Care Equity 555408.0 0.15
CARA CARA THERAPEUTICS INC Health Care Equity 546942.9 0.15
PAHC PHIBRO ANIMAL HEALTH CORP CLASS A Health Care Equity 538981.5 0.15
AVIR ATEA PHARMACEUTICALS INC Health Care Equity 420447.12 0.11
PHAT PHATHOM PHARMACEUTICALS INC Health Care Equity 373783.3 0.1
AERI AERIE PHARMACEUTICALS INC Health Care Equity 356513.4 0.1
XTSLA BLK CSH FND TREASURY SL AGENCY Cash and/or Derivatives Money Market 340000.0 0.09
SGAFT CASH COLLATERAL USD SGAFT Cash and/or Derivatives Cash Collateral and Margins 102000.0 0.03
IXCH2 E-MINI HEALTH CARE SECTOR MAR 22 Cash and/or Derivatives Futures 0.0 0.0
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY VEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The iShares Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Barclays, Bloomberg Finance L.P., BlackRock Index Services, LLC, Cohen & Steers Capital Management, Inc., European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Services, LLC, India Index Services & Products Limited, JPMorgan Chase & Co., Japan Exchange Group, MSCI Inc., Markit Indices Limited, Morningstar, Inc., The NASDAQ OMX Group, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), New York Stock Exchange, Inc., Russell or S&P Dow Jones Indices LLC. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE nor NAREIT makes any warranty regarding the FTSE NAREIT Equity REITS Index, FTSE NAREIT All Residential Capped Index or FTSE NAREIT All Mortgage Capped Index; all rights vest in NAREIT. Neither FTSE nor NAREIT makes any warranty regarding the FTSE EPRA/NAREIT Developed Real Estate ex-U.S. Index, FTSE EPRA/NAREIT Developed Europe Index or FTSE EPRA/NAREIT Global REIT Index; all rights vest in FTSE, NAREIT and EPRA.“FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2021 BlackRock, Inc. All rights reserved. iSHARES and BLACKROCK are registered trademarks of BlackRock, Inc., or its subsidiaries. All other marks are the property of their respective owners. ICRMH0421U/S-1620308 nan nan nan nan nan